Summary & Overview
CPT 0257U: VLCAD Enzyme Activity Assay, Blood (MS/MS)
CPT code 0257U is a Proprietary Laboratory Analyses (PLA) code that identifies a single, manufacturer‑ or lab‑specific test: Very–Long Chain Acyl–CoA Dehydrogenase (VLCAD) Enzyme Activity measured in leukocytes from a blood specimen using tandem mass spectrometry (MS/MS). The assay supports diagnosis and management of VLCAD deficiency, a potentially life‑threatening disorder of fatty‑acid oxidation, making the code important for rare disease detection and targeted treatment planning nationwide. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical purpose of the test, typical sites of service, common billing modifiers, and which payers are addressed. The publication also highlights what to expect in payer coverage patterns for proprietary laboratory assays, benchmark considerations for specialized enzymatic testing, and relevant clinical context for VLCAD deficiency. Data not available in the input for specific payer coverage policies, associated taxonomies, and ICD‑10 diagnoses are noted as unavailable. This summary is intended for national audiences involved in clinical laboratory operations, medical billing, and health policy related to rare metabolic disease testing.
Billing Code Overview
CPT code 0257U is a Proprietary Laboratory Analyses (PLA) code for Very–Long Chain Acyl–CoA Dehydrogenase (VLCAD) Enzyme Activity, performed by the Children’s Hospital Colorado Laboratory on a blood specimen. The test measures VLCAD enzyme activity in leukocytes using tandem mass spectrometry (MS/MS) to aid in diagnosis and treatment planning for VLCAD deficiency, a severe fatty–acid metabolism disorder.
Service type: Laboratory — specialized biochemical enzyme assay
Typical site of service: Clinical laboratory / reference laboratory (blood specimen collection typically in an outpatient or hospital setting)
Clinical & Coding Specifications
Clinical Context
A neonate or infant with abnormal newborn screening results for fatty acid oxidation disorders is referred to a metabolic genetics clinic. The patient presents with feeding intolerance, hypoglycemia, lethargy, or cardiomyopathy, or a family history of Very–Long Chain Acyl–CoA Dehydrogenase (VLCAD) deficiency. A peripheral blood sample is collected in appropriate anticoagulant tubes and sent to Children’s Hospital Colorado Laboratory for laboratory testing. The laboratory performs leukocyte isolation and uses tandem mass spectrometry (MS/MS) to measure VLCAD enzyme activity. Results are reported back to the ordering metabolic geneticist or pediatrician and are used to confirm biochemical diagnosis, guide immediate medical management (for example, dietary fat restriction and emergency care plans), and inform genetic counseling and further molecular testing of the ACADVL gene when indicated. Typical site of service is an outpatient hospital or specialized pediatric laboratory; sample collection often occurs in an outpatient clinic, newborn nursery, or inpatient pediatric unit. The service type is a specialized enzymatic diagnostic test (Proprietary Laboratory Analysis) performed by a single laboratory.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard reporting | Use when no special modifier applies; report baseline PLA test. |
22 | Increased procedural services | Use if unusually high laboratory work or complexity beyond typical workflow is documented. |
26 | Professional component | Use when only the professional component (interpretation or report) is billed separately from technical component. |
52 | Reduced services | Use if the test was performed but not completed to full extent and a reduced service is billed. |
53 | Discontinued procedure | Use if specimen collection or testing was started but discontinued for documented clinical reasons. |
62 | Two surgeons — co-surgeons (laboratory equivalent rarely used) | Rarely applicable; used if two independent laboratories/providers share responsibility for professional component. |
78 | Unplanned return to operating/procedure room by same physician following initial procedure (laboratory context) | Use if repeat urgent specimen processing is required due to initial assay failure and documentation supports same-day return to provision of services. |
80 | Assistant surgeon (laboratory equivalent) | Rarely used; applies if an assisting professional's services are separately billable for the professional component. |
TC | Technical component | Use when billing only the technical component of the test (laboratory processing, reagents, instrumentation). |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207Q00000X | Medical Genetics | Providers who order and interpret metabolic enzyme testing and manage inherited metabolic disorders. |
| 207L00000X | Pediatric Neurology (Metabolic) | Pediatric subspecialists involved when neurologic manifestations drive testing and follow-up. |
| 207RP1001X | Pediatric Medicine | General pediatricians and neonatologists who initiate newborn screening follow-up and specimen collection. |
| 207K00000X | Clinical Laboratory Director | Laboratory medicine specialists who oversee testing methodology, quality, and reporting. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
E71.321 | Very long-chain acyl-CoA dehydrogenase deficiency | Direct indication for VLCAD enzyme activity testing to confirm diagnosis and guide management. |
E71.30 | Fatty-acid oxidation disorder, unspecified | Used when a fatty-acid oxidation disorder is suspected based on newborn screening or clinical presentation prior to specific diagnosis. |
P78.4 | Hypoglycemia of newborn | Newborns presenting with hypoglycemia may undergo enzymatic testing to evaluate fatty acid oxidation defects including VLCAD deficiency. |
I42.8 | Other cardiomyopathies | VLCAD deficiency can present with cardiomyopathy; testing is relevant in infants with unexplained cardiomyopathy. |
R62.0 | Delayed milestone in childhood | Developmental concerns with metabolic etiologies prompt enzymatic and genetic evaluation including VLCAD testing. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
36415 | Collection of venous blood by venipuncture | Often performed prior to sending a blood specimen to the lab for leukocyte isolation and VLCAD enzyme assay. |
81025 | Urine pregnancy test, by dipstick or tablet reagent, non-automated, qualitative (optional example) | Not directly related but commonly performed in baseline evaluations for adolescent patients when indicated; included here as a general ancillary test code often billed in pediatric workflows. |
81479 | Unlisted molecular pathology procedure | Used when follow-up genetic testing (ACADVL sequencing or targeted panels) is performed and no specific molecular CPT exists for the particular test ordered; may be used in coordination with enzyme assay for definitive diagnosis. |
82542 | Creatine kinase; total (CK) | May be ordered as an adjunctive laboratory test when muscle involvement or cardiomyopathy is suspected in VLCAD deficiency. |